Spanish researchers have unveiled a new CAR-T cell therapy which offers promise for treating Hodgkin’s disease and other refractory CD30+ lymphomas.
The treatment targets the CD30 protein and a phase I trial has found improved clinical outcomes in...
10 months ago
Regular monitoring using a sensitive bone marrow test can significantly improve survival of some younger adults with acute myeloid leukaemia (AML), British researchers have reported.
The trial, reported in The Lancet Haematology, found that minima...
10 months ago
